文献速递银屑病与炎症性皮肤病皮肤肿瘤

银屑病患者黑色素瘤与血液系统肿瘤风险研究

The risk of melanoma and hematologic cancers in patients with psoriasis.
PubMed 文献 · J Am Acad Dermatol · 2016-11-19

该病例对照与回顾性队列研究评估银屑病患者黑色素瘤及血液系统肿瘤风险及与治疗的关系。银屑病患者发生恶性肿瘤的风险为非银屑病患者的1.53倍(P < .01),但外用、光疗、系统或生物制剂治疗间恶性肿瘤风险无显著差异,且合并恶性肿瘤的银屑病患者生存未显著更差。

要点

  • 银屑病患者恶性肿瘤风险为无银屑病者的1.53倍(P < .01)。
  • 外用、光疗、系统或生物制剂治疗间恶性肿瘤风险无显著差异。
  • 合并恶性肿瘤的银屑病患者生存未显著差于无银屑病者。

核心结论

  • 银屑病患者较一般人群可能存在黑色素瘤和血液系统肿瘤风险升高。
  • 系统或生物制剂治疗未增加该风险。

研究设计与样本

  • 采用病例对照和回顾性队列设计评估银屑病患者黑色素瘤或血液系统肿瘤风险。
  • 采用Fisher精确检验评估不同治疗类型的风险。

主要发现

  • 银屑病患者发生恶性肿瘤的风险为非银屑病患者的1.53倍(P < .01)。
  • 外用、光疗、系统或生物制剂治疗的患者间恶性肿瘤风险无显著差异。
  • 合并恶性肿瘤的银屑病患者生存未显著差于无银屑病患者。

临床怎么用

  • 银屑病患者应关注黑色素瘤和血液系统肿瘤风险,但系统或生物制剂治疗不增加风险。

局限性

  • 患者可能在研究随访时间之后发生恶性肿瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risk of melanoma and hematologic cancers in patients with psoriasis is controversial. OBJECTIVE: We sought to assess the risk of melanoma and hematologic cancers in patients with psoriasis, and the association with different treatments. METHODS: We used case-control and retrospective cohort designs to determine melanoma or hematologic cancer risk in patients with psoriasis. Risk with treatment type was assessed using Fisher exact test. RESULTS: Patients with psoriasis had 1.53 times greater risk of developing a malignancy compared with patients without psoriasis (P < .01). There were no significant differences in malignancy risk among patients treated with topicals, phototherapy, systemics, or biologic agents. Patients with psoriasis and malignancy did not have significantly worse survival than patients without psoriasis. LIMITATIONS: It is possible that patients developed malignancy subsequent to the follow-up time included in the study. CONCLUSION: Patients with psoriasis may experience an elevated risk of melanoma and hematologic cancers, compared with the general population. The risk is not increased by systemic or biologic psoriasis therapies.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Reddy SP, Martires K, Wu JJ, et al. The risk of melanoma and hematologic cancers in patients with psoriasis. J Am Acad Dermatol. 2016. PMID: 27876302. doi:10.1016/j.jaad.2016.09.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。